Neutralization of Different Variants of SARS-CoV-2 by a F(ab')2 Preparation from Sera of Horses Immunized with the Viral Receptor Binding Domain

• Published in: Antibodies (Basel) Vol. 12; no. 4; p. 80
• Main Authors: Rodriguez-Nuñez, Mariajosé, Cepeda, Mariana Del Valle, Bello, Carlos, Lopez, Miguel Angel, Sulbaran, Yoneira, Loureiro, Carmen Luisa, Liprandi, Ferdinando, Jaspe, Rossana Celeste, Pujol, Flor Helene, Rangel, Héctor Rafael
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 07.12.2023
• Subjects: Animals; Antibodies; Antigens; Binding; Cell adhesion; COVID-19; Disease transmission; equine sera; evolution; Genomes; Horses; immune escape; Immunization; Infections; Mutation; Neutralization; Neutralizing; neutralizing antibodies; Pandemics; Proteins; Receptors; Reduction; RNA polymerase; Severe acute respiratory syndrome coronavirus 2; Spike protein; Strains (organisms); Toxicity; Vaccines; variants; Viral diseases; Viruses; United Kingdom > UK; South Africa; COVID-19; neutralizing antibodies; immune escape; evolution; variants; equine sera
• ISSN: 2073-4468; 2073-4468
• DOI: 10.3390/antib12040080

The Receptor Binding Domain (RBD) of SARS-CoV-2, the virus responsible for the COVID-19 pandemic, is the functional region of the viral Spike protein (S), which is involved in cell attachment to target cells. The virus has accumulated progressively mutations in its genome, particularly in the RBD region, many of them associated with immune evasion of the host neutralizing antibodies. Some of the viral lineages derived from this evolution have been classified as Variant of Interest (VOI) or Concern (VOC). The neutralizing capacity of a F(ab')2 preparation from sera of horses immunized with viral RBD was evaluated by lytic plaque reduction assay against different SARS-CoV-2 variants. A F(ab')2 preparation of a hyperimmune serum after nine immunizations with RBD exhibited a high titer of neutralizing antibodies against the ancestral-like strain (1/18,528). A reduction in the titer of the F(ab')2 preparation was observed against the different variants tested compared to the neutralizing activity against the ancestral-like strain. The highest reduction in the neutralization titer was observed for the Omicron VOC (4.7-fold), followed by the Mu VOI (2.6), Delta VOC (1.8-fold), and Gamma VOC (1.5). Even if a progressive reduction in the neutralizing antibodies titer against the different variants evaluated was observed, the serum still exhibited a neutralizing titer against the Mu VOI and the Omicron VOC (1/7113 and 1/3918, respectively), the evaluated strains most resistant to neutralization. Therefore, the preparation retained neutralizing activity against all the strains tested.